JUN 14, 2017 1:33 PM PDT

New Genetic Markers Found For Testicular Cancer


Genetic testing now exists for a number of cancers in the reproductive organs, such as ovarian and breast cancer. However, it’s surprising that genetic testing for testicular cancer isn’t as far along in development. But now, researchers at the Institute of Cancer Research in London say that they’ve found a number of new genetic markers associated with the male disease.

Image credit: Pixabay.com

Testicular cancer is not very common as compared to other cancers. A man’s lifetime risk of developing the disease is less 0.5 percent. Treatment is based on the tumor grade, and can include surgery, radiation therapy, chemotherapy, and even high-dose chemotherapy with stem cell transplant.

In hoping to further the genetic knowledge of testicular cancer, the research team analyzed DNA samples from over 7,300 men with testicular germ cell cancer (TGCT). They compared these genetic profiles to those of over 23,000 healthy men.

The analysis yielded a considerable number of new genetic loci that are associated with testicular cancer risk. "With this analysis, we've identified eight new loci in previously unknown regions, said Katherine Nathanson, professor at the University of Pennsylvania, and the study’s lead author. "We've also found four new loci in previously identified regions."

This "roughly [doubles] the number of known TGCT risk loci to 44," they wrote. In particular, the genetic regions also have biological relevance to the disease - some associated genes are involved in the male germ cell development and maturation.

"Compared to other cancer types, we have accounted for a high proportion of site-specific heritability with fewer loci," Nathanson said. Furthermore, Nathanson believes the collection of genetic markers could explain 37 percent of hereditary testicular cancer, that is testicular cancer that’s passed from father to son.

"Even though this cancer is curable, it shows how much we still have to learn about this particular disease type," Nathanson said. "These findings can guide us when trying to determine which patients are at a high risk of developing disease and who among them should be screened."

Additional source: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 10, 2019
OCT 10, 2019
Parkinson's Disease is Present in the Blood
Parkinson's disease is a progressive disorder of the nervous system. Often starting with a barely noticeable tremor in one hand, the disease affects a
NOV 01, 2019
Chemistry & Physics
NOV 01, 2019
Cancer Therapy Agents Inspired by Solar Technology
In a recent study, a group of biomedical researchers at Michigan State University developed a new platform for tweaking light-activated dyes that can enable diagnostic imaging, image-guided s
NOV 27, 2019
Health & Medicine
NOV 27, 2019
3D-printed cell traps catch cancer cells on the move
The early stages of metastasis, or the spread of cancer cells from the primary tumor site, are incredibly difficult to detect by analyzing blood samples. F
DEC 04, 2019
Clinical & Molecular DX
DEC 04, 2019
Genetic platform takes the guesswork out of catching infections
A physician is faced with 3 patients: an elderly person with a chronic cough, a child being wheeled out of surgery and a young mother with a high fever. Ho
FEB 10, 2020
FEB 10, 2020
As Ebola Outbreak Continues, Researchers Create Faster Genetic Test
Since 2013, around 30,000 people have been infected during several outbreaks of Ebola in eight different countries.
MAR 24, 2020
Genetics & Genomics
MAR 24, 2020
Crumpling Graphene Makes It an Ultra-Sensitive Biosensor
Liquid biopsies often need to make many copies of RNA or DNA before they are detectable. New research aims to change that.
Loading Comments...